That’s according to a bombshell new report from the VA Office of the Inspector General, released on Tuesday., Oct. 10.
This breakthrough could help providers pinpoint other neurological conditions, experts noted in a study published Wednesday, Dec. 11, in Radiology: Artificial Intelligence.
Both are aimed at bolstering radiation therapy planning, the company announced on Wednesday, Dec. 11.
Using positron emission tomography to diagnose coronary artery disease does not return better outcomes than the norm, stress echocardiography, and is not offset by downstream monetary savings.
The federal agency responsible for clearing new artificial intelligence algorithms wants to better understand the pitfalls of this technology’s burgeoning use in imaging.
A task force developed the recommendations using feedback from several experts and best practices gathered from more than 100 studies.
"Placing unfettered power in these occurrences in the hands of insurers would impact access to care that neither patients, providers or the government will be happy with," said CEO William Thorwarth, MD.
Funding from the Gordon and Betty Moore Foundation will assist the college in developing a measure to ensure that cancer patients aren’t slipping through the cracks.
Researchers with Beth Israel Deaconess Medical Center, in Boston, recently made that discovery through a years-long experiment involving tens of thousands of patients.
Clinical healthcare software firm Dedalus has entered into exclusive negotiations to acquire Agfa’s ORBIS EHR line and other related integrated-care products.
Assistant Secretary of Defense Thomas McCaffery recently confirmed this TRICARE change in a letter to members of Congress.
The chief of the Journal of the American College of Radiology recently made that declaration in a new editorial released on Thursday, Dec. 5.